Philip Morris International has confirmed a U.S. launch of ZYN ULTRA in June 2026, the biggest shake-up to America's best-selling nicotine pouch line in years. The new product arrives in 9mg and 11mg strengths, a moister pouch, a 20-count can, and — notably — a lower price-per-pouch than the classic ZYN you already know.
What happened
According to industry outlet Tobacco Insider, PMI is rolling out ZYN ULTRA as a direct expansion of the flagship ZYN portfolio. Three things make it different from standard ZYN. First, the format: ULTRA uses a slim, moist pouch, a departure from ZYN's signature mini, dry pouch. Second, the can: ULTRA ships 20 pouches per can versus the 15-pouch format used across most of the core range. Third, the price: PMI says ULTRA will sit at a lower price-per-pouch than flagship ZYN.
The strengths are stepping up too. ULTRA launches in 9mg and 11mg, higher than the 3mg and 6mg options that carry the bulk of ZYN's FDA-authorized lineup. PMI also signaled that more ZYN portfolio extensions are coming through the rest of 2026.
Why it matters
ZYN didn't add a moist, higher-count, lower-priced pouch out of nowhere. It's a defensive move. Tobacco Insider reports ULTRA is a response to ZYN's recent category share losses — particularly to VELO Plus, which has gained ground with a moist format, bigger can count, and aggressive pricing. Newer challengers like FRE and ALP have piled on the pressure in the fastest-growing corner of the pouch market.
In plain terms: the moist-pouch crowd has been eating into ZYN's lead, and ZYN is finally answering in the same language. For a category that's still posting double-digit growth — PMI reported U.S. ZYN consumer sales up more than 10% in the first quarter of 2026 — that competition is good news for anyone who buys pouches.
What this means for pouch fans
More competition usually means better deals, and ULTRA is built around value: more pouches per can at a lower per-pouch cost. If you've been a dry-pouch loyalist, the moist format delivers nicotine faster (though the experience tends to be shorter), so it's worth trying a can before you switch your whole rotation. And if you already lean toward stronger pouches, the jump to 9mg and 11mg puts ZYN in the same ring as the high-strength brands.
A quick reality check on legality and availability: only specific ZYN SKUs have FDA marketing authorization, and rollouts often reach different states at different times. Stock can be uneven early on — so if you spot ULTRA in the strength you want, it's worth grabbing.
“ZYN ULTRA will be positioned at a lower price-per-pouch than the core ZYN range,” Tobacco Insider reported, calling the move “an important step in optimizing ZYN's price premium within the rapidly evolving U.S. nicotine pouch category.”
The bottom line
ZYN ULTRA is the brand admitting the moist-pouch, big-can, value-priced playbook works — and joining it. Expect more strengths, flavors, and formats from ZYN before the year is out, and expect rivals to answer back. For everyday pouch buyers, that arms race mostly cuts one way: more choice, and better prices. We'll be watching the lineup and flagging the best deals as ULTRA hits shelves.
Sources: Tobacco Insider, CSP Daily News.
